UNSPSC 51284118: Ceftioxide

This classification denotes a cephalosporin antibiotic with the molecular formula C16H17N5O8S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Z9DV0V6TG, chemically known as (5s,6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-2-ene-carboxylic acid 7,2-(z)-(o-methyloxime), acetate (ester), 5-oxide but generally known as ceftioxide, which bears US NIH Compound Identifier 9589416.

UNSPSC 51284118 Ceftioxide, a Commodity code, shows no active state and local procurement activity aligned with its nominal scope in the recent opportunities block. The two posted opportunities under this code are unrelated to ceftioxide — one concerns Doxycycline Hyclate and Ciprofloxacin Hydrochloride pharmaceutical distribution via a piggyback contract, and the other addresses Naloxone and drug deactivation systems procurement. Neither involves the antibiotic product specified by the code. This mismatch between code assignment and actual solicitation scope suggests either tagging error by the issuing bodies or a data classification issue. Pharmaceutical procurement does flow through state health departments and county health systems, but the specific products being bought do not align with ceftioxide.

Without recent opportunities genuinely soliciting ceftioxide supply, a concrete assessment of issuing-body mix, geographic concentration, or typical contract size is not supported by the source. The Illinois Department of Public Health and Seminole County, Florida appear in the recent record, but neither is soliciting the product named by the code. A business development professional evaluating this code should verify whether recent ceftioxide solicitations exist outside this dataset and clarify the correct UNSPSC assignment for antibiotic pharmaceutical procurement before committing resources to pursuit.